Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.
The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.
"This is a potentially important breakthrough for the Gynecologic Oncology Group," said John Farley, MD, a gynecologic oncologist in the Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology at the Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, a Dignity Health Member.
The Gynecologic Oncology Group is a non-profit international organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies.
Dr. Farley is part of the University of Arizona Cancer Center at St. Joseph's and is board certified in obstetrics and gynecology with a subspecialty certification in gynecologic oncology. He is a retired decorated Army colonel who completed a residency in obstetrics and gynecology and a fellowship in gynecologic oncology at Walter Reed Army Medical Center. He is the first author on this study.
This study was initially developed in 2007, with 52 patients enrolled for the Phase II clinical trial between December 2007 and November 2009. Patients were given 50 milligrams of selumetinib orally twice daily. Of those participants, eight had a measurable decrease in tumor size, seven had partial responses and 34 patients saw their tumors stabilize. The findings suggest that inhibitors of the MAPK pathway warrant further investigation in patients with low-grade ovarian cancer.
"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us," Dr. Farley said. He added that Phase III of this trial is scheduled to begin in the next few weeks, with that trial to be the "definitive test" before the treatment becomes available to the general population.
This study is registered with ClinicalTrials.gov, number NCT00551070.
About The University of Arizona Cancer Center
The University of Arizona Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center headquartered in Arizona. The UACC is supported by NCI Cancer Center Support Grant number CA023074. With primary locations at the University of Arizona in Tucson and at St. Joseph's Hospital and Medical Center in Phoenix, the Cancer Center has more than a dozen research and education offices in Phoenix and throughout the state and 300 physician and scientist members work together to prevent and cure cancer. For more information, go to http://www.arizonacancercenter.org
About St. Joseph's Hospital and Medical Center
Located in the heart of Phoenix, Ariz., St. Joseph's Hospital and Medical Center is a 607-bed, not-for-profit hospital that provides a wide range of health, social and support services with special advocacy for the poor and underserved. St. Joseph's is a nationally recognized center for quality tertiary care, medical education and research. It includes the internationally renowned Barrow Neurological Institute, the Heart & Lung Institute, the Muhammad Ali Parkinson Center, and a Level I Trauma Center verified by the American College of Surgeons. U.S. News & World Report routinely ranks St. Joseph's among the best hospitals in the United States for neurology and neurosurgery.
Laboratory study: Scientists from Cologne explore a new approach to prevent newborn epilepsies
24.11.2015 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
U of T research sheds new light on mysterious fungus that has major health consequences
23.11.2015 | University of Toronto
Normalerweise werden Unterwasser-Roboter über lange Kabel von Booten oder von Land aus gesteuert. Forschern der Jacobs University in Bremen ist nun ein Durchbruch in der Mensch-Maschine-Kommunikation gelungen: Erstmals konnten sie einen Unterwasser-Roboter mit Hilfe von Gesten navigieren. Eine spezielle Kamera half dabei, die Zeichensprache in Befehle umzusetzen. Die Feldtests fanden im Rahmen des EU-geförderten Projektes CADDY „Cognitive Autonomous Diving buddy“ statt.
Archäologische Untersuchungen im Ozean und vergleichbare komplexe Forschungsprojekte unter Wasser sind auf die Unterstützung von Robotern angewiesen, um in...
Nerve cells cover their high energy demand with glucose and lactate. Scientists of the University of Zurich now provide new support for this. They show for the first time in the intact mouse brain evidence for an exchange of lactate between different brain cells. With this study they were able to confirm a 20-year old hypothesis.
In comparison to other organs, the human brain has the highest energy requirements. The supply of energy for nerve cells and the particular role of lactic acid...
Die Simulation von Prozessen bei der Lasermaterialbearbeitung ist in den letzten Jahren immer besser geworden. Die Software kann heute relativ gut voraussagen, was am Werkstück passiert. Leider ist sie hochkomplex und erfordert viel Rechenzeit. Durch eine clevere Vereinfachung können Experten vom Fraunhofer-Institut für Lasertechnik ILT erstmals eine Simulationssoftware anbieten, die Prozesse in Echtzeit rechnet und auch auf Tablets oder Smartphones läuft. Mit der schnellen Software lassen sich teure Versuche einsparen und noch besser optimale Prozessparameter finden.
Eine verlässliche Simulation von Laserprozessen war bislang eine Sache für Experten. Mit ausgefeilten Software-Paketen und viel Zeit auf Computerclustern...
In laser material processing, the simulation of processes has made great strides over the past few years. Today, the software can predict relatively well what will happen on the workpiece. Unfortunately, it is also highly complex and requires a lot of computing time. Thanks to clever simplification, experts from Fraunhofer ILT are now able to offer the first-ever simulation software that calculates processes in real time and also runs on tablet computers and smartphones. The fast software enables users to do without expensive experiments and to find optimum process parameters even more effectively.
Before now, the reliable simulation of laser processes was a job for experts. Armed with sophisticated software packages and after many hours on computer...
Heidelberger Physiker imitieren mit ultrakalten Atomen das Verhalten von Elektronen in einem Festkörper
Einen neuen Ansatz zur Erforschung des Phänomens Magnetismus haben Wissenschaftler der Universität Heidelberg entwickelt. Mithilfe von ultrakalten Atomen nahe...
24.11.2015 | Veranstaltungen
24.11.2015 | Veranstaltungen
23.11.2015 | Veranstaltungen
24.11.2015 | Materialwissenschaften
24.11.2015 | Messenachrichten
24.11.2015 | Messenachrichten